PeterKHonigMDMPH

Clinical Pharmacology

Private Equity

Dr. Honig is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClincal Pharmacology, 1990 - 1992
Columbia University School of Public HealthMPH, 1986 - 1989
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1982 - 1985
Columbia University Vagelos College of Physicians and SurgeonsClass of 1982

FDA Alumni Award FDA, 2020
Gary Neil Innovation in Drug Development Award ASCPT, 2016
Sol Katz Excellence in Teaching Award Georgetown University Dept of Medicine, 1996

PubMed

20 citations
Application of Bayesian approaches in drug development: starting a virtuous cycle.
Stephen J Ruberg, Francois Beckers, Rob Hemmings, Peter Honig, Telba Irony
Nature Reviews. Drug Discovery. 2023-03-01
14 citations
A Useful and Sustainable Role for N-of-1 Trials in the Healthcare Ecosystem.
Harry P. Selker, Theodora Cohen, Ralph B. D'Agostino, Willard H. Dere, S. Nassir Ghaemi
Clinical Pharmacology and Therapeutics. 2021-10-20
510 citations
Terfenadine-Ketoconazole Interaction: Pharmacokinetic and Electrocardiographic Consequences
Peter K. Honig, Dale C. Wortham, Kaveh Zamani, Dale P. Conner, James C. Mullin
JAMA. 1993-03-24

Multidisciplinary Research Team Led by Tufts CTSI Proposes New Model for Clinical TrialsFebruary 10th, 2016